| Entry |
|
|---|
| Name |
Pelitinib (USAN/INN) |
|---|
| Formula |
C24H23ClFN5O2
|
|---|
| Exact mass |
467.1524
|
|---|
| Mol weight |
467.92
|
|---|
| Structure |
|
|---|
| Class |
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG01917 Receptor tyrosine kinase inhibitor
|
|---|
| Efficacy |
Antineoplastic, Receptor tyrosine kinase inhibitor |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG01917 Receptor tyrosine kinase inhibitor
D05399 Pelitinib
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
EGFR family
EGFR
D05399 Pelitinib (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 33
1 C8y C 18.1063 -14.1346
2 C8y C 18.1063 -12.7492
3 C8x C 16.9287 -12.0566
4 C8y C 15.6819 -12.7492
5 C8y C 15.6819 -14.1346
6 C8x C 16.9287 -14.8272
7 N5x N 14.5044 -12.0566
8 C8x C 13.3268 -12.7492
9 C8y C 13.3268 -14.1346
10 C8y C 14.5044 -14.8272
11 N1b N 14.5044 -16.2126
12 C8y C 15.6819 -16.9053
13 C3b C 12.1493 -14.8272
14 N3a N 10.9025 -15.5199
15 C8x C 16.8594 -16.2126
16 C8x C 18.1063 -16.9053
17 C8y C 18.1063 -18.2906
18 C8y C 16.9287 -18.9833
19 C8x C 15.6819 -18.2906
20 X F 19.2838 -18.9833
21 X Cl 16.9287 -20.3686
22 O2a O 19.3434 -12.0416
23 C1b C 19.3434 -10.6416
24 C1a C 20.5388 -9.9512
25 N1b N 19.3417 -14.8413
26 C5a C 20.5356 -14.1455
27 C2b C 21.7291 -14.8282
28 O5a O 20.5300 -12.7401
29 C2b C 22.9119 -14.1390
30 C1b C 24.1110 -14.8250
31 N1c N 25.2910 -14.1374
32 C1a C 26.4914 -14.8243
33 C1a C 25.2854 -12.7401
BOND 35
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 2
9 8 9 1
10 9 10 2
11 5 10 1
12 10 11 1
13 11 12 1
14 9 13 1
15 13 14 3
16 12 15 2
17 15 16 1
18 16 17 2
19 17 18 1
20 18 19 2
21 12 19 1
22 17 20 1
23 18 21 1
24 2 22 1
25 22 23 1
26 23 24 1
27 1 25 1
28 25 26 1
29 26 27 1
30 26 28 2
31 27 29 2
32 29 30 1
33 30 31 1
34 31 32 1
35 31 33 1
|
|---|
